News archive 2003
New MD for KCL Enterprises18 Dec 2003, PR 84/03
Dr Alison Campbell has been appointed Managing Director of KCL Enterprises and will take up the post on 1 March 2004.
KCL Enterprises is a wholly owned subsidiary of King’s College London, responsible for the marketing, negotiation and financial administration of research, consultancy, and technology transfer activities of the College.
Dr Campbell will join KCL Enterprise from MRC Technology where she is the Acting Chief Executive, having previously been Director of the Intellectual Property Development Division. Before joining the MRC in 1991 she worked as a research scientist at Celltech.
King’s is in the top group of five universities for research earnings with income from grants and contracts of more than £93 million (2002-2003) with some 2,500 current research programmes. The College has recently entered into a long-term partnership with IP2IP0 to commercialise the College’s intellectual property through the formation and development of spin-out companies and licensing technologies.
Dr Alison Campbell said:
‘I am very pleased to be joining such a prestigious university. King’s has a clear commitment across its Schools to the spectrum of knowledge transfer and partnership with industry. I look forward to working with the team in KCL Enterprise to build on the strong foundation that has already been built.’
Professor Sir Lawrence Freedman, the Vice Principal (Research) commented:
‘We are delighted to have been able to attract to King's somebody with such an impressive track record in the technology transfer field. King's has long been to the fore in developing strong university-industry links, and with the increased interest in this area following the Lambert Report, Alison’s appointment will demonstrate the College’s continuing commitment to developing these links and maintaining its position as one of the country's leading research universities.’
Dr Campbell takes over from Dr Malcolm Sims who joined King’s in 1993 as the first ever Managing Director of KCL Enterprises. Under his leadership income from grants and contracts increased from £27 million to £93.4 million per annum, whilst more than 100 licences have been negotiated and 20 spin-out companies established.
Notes to editors
Dr Alison Campbell
Dr Campbell read Biochemistry at University College London and then researched for her PhD at Imperial College under the supervision of Professor Alan Fersht.
King’s College London
King’s is one of the oldest and largest colleges of the University of London with some 13,400 undergraduate students and some 5,000 postgraduates in ten schools of study. The College had 24 of its subject-areas awarded the highest rating of 5* and 5 for research quality, demonstrating excellence at an international level. King’s is a member of the Russell Group, a coalition of the UK’s major research-based universities, and has an annual turnover of £320 million.
Public Relations Department
Tel: 020 7848 3202
Centre For Chemical Biology
Science programme changes at King’s College London
World first: London team pioneers new technique for children born with heart defects
Strategic Review: Chemistry
This information is provided by the Public Relations Department
Tel: 020-7848 3202 Fax: 020-7848 3739 Email: email@example.com